Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

People with primary immunodeficiencies often have frequent, severe, or unusual infections and may need special tests and management strategies.

The analysis of a large pilomatricoma revealed five distinct areas with different gene activity related to hair growth and tumor development.

The conclusion is that a certain test might help find cancer spread in lymph nodes for melanoma patients, but more research is needed due to false positives.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

The analyses helped identify different skin diseases in the two dogs.

Inflammation damages sweat ducts, causing sweat gland injury.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

CD2 might be a new treatment target for patchy alopecia areata.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Cell adhesion molecules are important in the development of certain skin diseases.

Different γδ T cell types have unique roles in causing alopecia areata.

The study found that diseases can be grouped by symptoms and that the accuracy of predicting disease-related genes varies with the data source.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

The humanized AA mouse model is better for testing new alopecia areata treatments.

New therapies aim to improve long-term hair regrowth in alopecia areata by targeting immune responses.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.